0 évaluation0% ont trouvé ce document utile (0 vote)
33 vues12 pages
Chronic kidney disease (CKD) is a pathophysiological progressive process of the loss of nephron number and function. It can be cause by multiple etiologies mainly by diabetes, hypertension, glomerulonephritis and polycystic kidney disease. The symptoms include gastrointestinal tract symptoms such as anorexia, nausea, vomiting, diarrheae; skin manifestations such as pruritus, dry skin, ecchymosis; fatique, increased
Chronic kidney disease (CKD) is a pathophysiological progressive process of the loss of nephron number and function. It can be cause by multiple etiologies mainly by diabetes, hypertension, glomerulonephritis and polycystic kidney disease. The symptoms include gastrointestinal tract symptoms such as anorexia, nausea, vomiting, diarrheae; skin manifestations such as pruritus, dry skin, ecchymosis; fatique, increased
Droits d'auteur :
Attribution Non-Commercial (BY-NC)
Formats disponibles
Téléchargez comme DOCX, PDF, TXT ou lisez en ligne sur Scribd
Chronic kidney disease (CKD) is a pathophysiological progressive process of the loss of nephron number and function. It can be cause by multiple etiologies mainly by diabetes, hypertension, glomerulonephritis and polycystic kidney disease. The symptoms include gastrointestinal tract symptoms such as anorexia, nausea, vomiting, diarrheae; skin manifestations such as pruritus, dry skin, ecchymosis; fatique, increased
Droits d'auteur :
Attribution Non-Commercial (BY-NC)
Formats disponibles
Téléchargez comme DOCX, PDF, TXT ou lisez en ligne sur Scribd
Chronic kidney disease (CKD) is a pathophysiological progressive process of the loss of nephron number and function that will results in end-stage renal disease (ESRD). t can be cause by multiple etiologies mainly by diabetes, hypertension, glomerulonephritis and polycystic kidney disease [1]. The symptoms of renal dysfunction must be present for at least 3 months for it to be considered chronic. The symptoms include gastrointestinal tract symptoms such as anorexia, nausea, vomiting, diarrheae; skin manifestations such as pruritus, dry skin, ecchymosis; fatique, increased somnolence, failure to thrive, malnutrition and many more [2]. Generally, these disturbances become clinically manifest with CKD stage 4-5 with glomerular filtration rate of < 30mL/min. For young women with renal insufficiency, it is important to have a counselling regarding fertility and pregnancy outcome. Successful pregnancy prognosis can be estimated by considering arbitrary categories of renal function that include normal or mild impairment, defined as serum creatinine of less than 1.5mg/dL; moderate impairment, defined as a serum creatinine of 1.5-3.0mg/dL and severe renal insufficiency, defined as a serum creatinine greater than 3.0mg/dL.
. RenaI Changes in NormaI Pregnancy n pregnancy, dramatic changes occur with respect to both renal plasma flow and glomerular filtration. By the second trimester, renal plasma flow increases approximately 75% above baseline, and then decreases by the end of the third trimester. The glomerular filtration rate is increased almost 50% by the end of the first trimester, and this rate is maintained throughout gestation. Glomerular filtration is clinically assessed by creatinine clearance, and because creatinine is also secreted by the renal tubules, the actual glomerular filtration rate is less than the measured creatinine clearance [3]. The overall effect of the increase in both renal plasma flow and glomerular filtration rate causes a decrease in the filtration fraction until the third trimester, when renal plasma flow falls slightly. Changes to the kidney during normal pregnancies are summarized in the table below: Table 1. Renal Changes in Normal Pregnancy [4] AIteration CIinicaI ReIevance ncreased renal size Renal length approximately 1 cm greater on radiographs Postpartum decreases in size should not be mistaken for parenchymal loss Dilatation of pelves, calyces, and ureters
Resembles hydronephrosis on ultrasound or VP (more marked on right)
Not to be mistaken for obstructive uropathy; retained urine leads to collection errors; upper urinary tract infections are more virulent; may be responsible for "distention syndrome" elective pyelography should be deferred to at least 12 weeks postpartum ncreased renal hemodynamics
Glomerular filtration rate and renal plasma flow increase ~50%
Serum creatinine and urea nitrogen values decrease during normal gestation; >0.8mg/dL (> 72 mol/L) creatinine already suspect; protein, amino acid, and glucose excretion all increase Changes in acidbase metabolism
Renal bicarbonate threshold decreases; progesterone stimulates respiratory center
Serum bicarbonate and Pco 2 are 45 mEq/L and 10 mm Hg lower, respectively, in normal gestation; a Pco 2 of 40 mm Hg already represents CO 2 retention Renal water handling Osmoregulation altered: osmotic thresholds for AVP release and thirst decrease; hormonal disposal rates increase
Serum osmolality decreases 10 mOsm/L (serum Na ~ 5 mEq/L) during normal gestation; increased metabolism of AVP may cause transient diabetes insipidus in pregnancy
AVP =vasopressin; VP = intravenous pyelography. Maternal posture may also have influence on several aspects of renal function. n example, late in pregnancy, urinary flow and sodium excretion average less than half the excretion rate in the supine position compared with that in the lateral recumbent position. The impact of posture on glomerular filtration and renal plasma flow is much more variable. The amounts of various nutrients such as amino acids and water soluble vitamins excreted in the urine of pregnant women is in much greater amounts than in nonpregnant women The physiological changes in renal hemodynamics induced during normal pregnancy have several implications for the interpretation of tests of renal function. Serum creatinine and urea nitrogen levels decrease from a mean of 0.7 and 1.2 mg/dL to 0.5 and 0.9 mg/dL, respectively, whereas values of 0.9 and 1.4 mg/dL suggest underlying renal disease and should prompt further evaluation. Creatinine clearance in pregnancy should be 30 percent higher than the 100 to 115 mL/min normally measured in non pregnant women. Creatinine clearance is a useful test to estimate renal function in pregnancy provided that complete urine collection is made during an accurately timed period. During the day, pregnant women tend to accumulate water in the form of dependent edema, and at night, while recumbent, they mobilize this fluid and excrete it via the kidneys. This reversal of the usual nonpregnant diurnal pattern of urinary flow causes nocturia, and the urine is more dilute than in the nonpregnant state. Failure of a pregnant woman to excrete concentrated urine after withholding fluids for approximately 18 hours does not signify renal damage. The kidney in these circumstances functions perfectly normally by excreting mobilized extracellular fluid of relatively low osmolality. Glucosuria during pregnancy is not necessarily abnormal. The appreciable increase in glomerular filtration, together with impaired tubular reabsorptive capacity for filtered glucose, accounts in most cases for glucosuria. Even though glucosuria is common during pregnancy, the possibility of diabetes mellitus should not be ignored when it is identified. Proteinuria normally is not evident during pregnancy except occasionally in slight amounts during or soon after vigorous labor. Albumin excretion is minimal and ranges from 5 to 30 mg/day. Hematuria if not the result of contamination during collection, most often suggests a diagnosis of urinary tract disease. Difficult labor and delivery, of course, can cause hematuria because of trauma to the lower urinary tract. . Water MetaboIism in NormaI Pregnancy ncreased water retention is a normal physiological alteration of pregnancy. This retention is mediated by a fall in plasma osmolality induced by a resetting of osmotic thresholds for thirst and vasopressin secretion. At term, the water content of the fetus, placenta, and amnionic fluid amounts to about 3.5 L. Another 3.0 L accumulates as a result of increases in the maternal blood volume and in the size of the uterus and the breasts. Thus, the minimum amount of extra water of an average women during normal pregnancy is about 6.5 L. Demonstrable pitting oedema of the ankles and legs is seen in most pregnant women, especially at the end of the day. This accumulation of fluid, which may amount to a litre or so, is caused by an increase in venous pressure below the level of the uterus as a consequence of partial occlusion of the vena cava. A decrease in interstitial colloid osmotic pressure induced by normal pregnancy also favours oedema late in pregnancy. . EIectroIytes and MineraIs MetaboIism in NormaI Pregnancy n normal pregnancy, plasma osmolality is decreased approximately 10 mOsm/kg H 2 O due to a decrease in the concentration of sodium. Despite the decreased serum concentration, there is an overall increase of almost 1000 mEq of sodium in the maternal intravascular and interstitial fluids, fetus, and placenta. Sodium loss is increased by the elevated glomerular filtration rate and by progesterone that promotes natriuresis. This is offset by a dramatic increase in renal tubular reabsorption of sodium, which is due to a dramatic increase in levels of the hormones aldosterone, deoxycortisone, and estrogen. Furthermore, angiotensinogen (renin substrate), angiotensin, and renin (the proteolytic enzyme that converts angiotensinogen to angiotensin ) levels jump, as well. The increase in these latter hormones aids in the increased production of aldosterone, which prevents sodium diuresis. Angiotensin , a product of angiotensin , is a potent vasoconstrictor. n normal pregnancy, sensitivity to the vasopressor effect of angiotensin is reduced. t is believed that increased production of uterine and placental prostaglandins, namely prostacyclin, plays an important role in blunting the normal vasoconstrictor effects of angiotensin . t is also believed that pregnancies that do not exhibit the normal decreased sensitivity to angiotensin are at greater risk for developing preeclampsia. Total serum calcium levels decline during pregnancy, the reduction reflecting lowered plasma albumin concentration and, in turn, the consequent decrease in the amount bound to protein. Since the developing fetus imposes a significant demand on maternal calcium homeostasis, dietary intake of sufficient calcium, therefore, is necessary to prevent excess depletion from the mother. This has been reported to be especially important in pregnant adolescents, whose own skeletons are still developing. Serum magnesium levels also decline during pregnancy. Compared with nonpregnant women, it is found that both total and ionized magnesium were significantly lower during normal pregnancy. On the other hand, serum phosphate levels are within the nonpregnant range. The renal threshold for inorganic phosphate excretion is elevated in pregnancy due to increased calcitonin.
5. Pregnancy and Chronic Kidney Disease (CKD) The recent redefinition of CKD led to the Kidney Disease Outcomes Quality nitiative (K/DOQ) guidelines on diagnosis and staging of CKD; these focus attention on the earlier stages of the disease, when persistent signs of renal damage are present but renal function may still be in the normal ranges. Because of this broader definition, it has been calculated that 3% of women of childbearing age are affected by CKD. The outcome of pregnancy in women with CKD is determined by the degree of renal insufficiency and hypertension. Other co-morbidities that contribute to adverse outcomes are diabetes and cardiopulmonary disease in which even when preserved renal function is normal and the woman is normotensive, pregnancy outcome is still not always good. t's also reported that there are high incidence of hypertension and preeclampsia, preterm and growth-restricted infants, as well as other problems in pregnancy with CKD. i. Physiological Changes With mild renal insufficiency, pregnancy is accompanied by increased renal plasma flow and glomerular filtration rate. These changes are thought to be induced by intrarenal vasodilation. With advanced renal disease, however, this vasodilation is already maximal and augmented flow is diminished to absent. Nonpregnant women with chronic renal insufficiency have blood volumes similar to healthy women. Blood volume expansion during pregnancy is dependent on disease severity, and it correlates inversely with serum creatinine concentration. n women with mild to moderate dysfunction, there is normal pregnancy-induced hypervolemia that averages 50 percent. n women with severe renal insufficiency, however, volume expansion averages only 25 percent. Finally, because there is only minimal pregnancy-induced erythropoiesis in these women, preexisting anemia is intensified. ii. Assessment of Renal Disease During Pregnancy The urinalysis is essential during pregnancy and at a patient's first prenatal visit, a urine analysis is performed, and the presence of glucose, protein, or casts should prompt an evaluation. A 24-hour urine collection for creatinine clearance and total protein should be done on patients with greater than trace protein on urine dip-stick analysis (and no UT). n normal pregnancy, total protein excretion should be less than 0.3 gm per day. There were no significant differences by trimester. Albumin constitutes only a small part of total protein excretion and ranges from 5 to 30 mg/day. Most investigators agree that proteinuria must exceed 300 to 500 mg/day to be considered abnormal for pregnancy. Creatinine clearance can decrease by almost 70% before there is an increase in serum blood urea nitrogen or creatinine. f the serum creatinine persistently exceeds 0.9 mg/dL (75 mol/L), then intrinsic renal disease should be suspected. A carefully collected, timed urine specimen can be used to estimate the glomerular filtration rate by creatinine clearance. Ultrasonography provides imaging of renal size and relative consistency, as well as elements of obstruction. Full-sequence intravenouspyelography is not done routinely, but injection of contrast media with one or two abdominal radiographs may be indicated by the clinical situation. The usual clinical indications for cystoscopy are followed. Orthostatic Proteinuria Abnormal amounts of protein are sometimes detectable in urine collected when the woman is ambulatory but not when recumbent and without other evidence of renal disease. Such orthostatic or postural proteinuria has been observed in up to 5 percent of normal young adults. The pregnant woman with orthostatic proteinuria should be evaluated for bacteriuria, abnormal urinary sediment, reduced glomerular filtration, and hypertension. n the absence of these abnormalities, orthostatic proteinuria is probably inconsequential. iii. Management Frequent prenatal visits are scheduled to monitor blood pressure. Some authorities suggest visits every 2 weeks until 28 weeks gestation and then weekly for 29 weeks gestation onwards [5]. Serial renal function is estimated with serum creatinine levels, and protein excretion is quantified if indicated. Women are screened and treated for bacteriuria to decrease the risk of pyelonephritis. Asymptomatic bacteriuria can be treated with a 3-day course of amoxicillin or cephalosporin, whereas trimethoprim-sulfamethoxazole, tetracyclines, and fluoroquinolones should be avoided [5]. Anemia from chronic renal insufficiency responds to recombinant erythropoietin, however, hypertension is a well- documented side effect. Protein excretion is measured frequently, usually by dipstick. f any worsening proteinuria is discovered, obtain a 24-urine collection. Protein-restricted diets however are not recommended [4]. DiaIysis in pregnancy Although pregnancy is uncommon in dialysis dependent patient it is not impossible. The outcome of pregnancies in women who conceive after starting dialysis remains poor. Only 59% of pregnancies that reach the second trimester result in surviving infants. Seventy-five percent of infants are born before 37 weeks of gestation and 25% are born before 28 weeks of gestation [6]. A dialysis regiment needs to be designed to improve the outcomes of the pregnancy. t is recommended for a pregnant ESRD patient to have at least 20 hours of dialysis weekly. Hou (2004) reported that infant survival did not improve until dialysis was increased to 20 hr per week or more. Although premature labor occurred in women on all dialysis regimens but stillbirths were limited to women dialyzed 15 hr/week or less. There are two dialysis modalities that can be considered for pregnancy. Hemodialysis and peritoneal dialysis do not show significant difference on the pregnancy outcomes but peritoneal dialysis in pregnant women is limited by the inability of patients to tolerate large volume exchanges late in pregnancy [6]. Hypertension is the most common life-threatening complication that can occur in dialysis patients. Fluid removal is still the first line of treatment for hypertension, but care must be taken to avoid hypotension that may be accompanied uterine hypoperfusion. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are clearly contraindicated in pregnancy. Calcium channel blockers are widely used but can inhibit labor and can cause profound hypotension when used in conjunction with magnesium [6]. Dialysis patients are dependent on exogenous erythropoietin for red cell production and hematocrit usually drops sharply (pregnancy is an unusual cause of ''erythropoietin resistance''). The drop in hematocrit has usually occurred by the time pregnancy is diagnosed and it is difficult for the erythropoietin dose to keep pace with the need. A doubling of the erythropoietin dose is usually needed to produce enough red cells for pregnancy and reverse the drop in hematocrit [6]. A quantity of 700 to 1000 mg of iron is needed in normal pregnancy. The daily iron requirement during the last half of pregnancy is 5 to 7 mg/day. The requirements for pregnant dialysis patients are not known but should be at least 1 g over and above their usual requirement. Table 2. Current general suggested practices for successful pregnancy on dialysis dependent women [7] Recommendations Details Explanation Preconceptional counseling for prospective mothers on chronic HD
Multidisplinary approach Joint efford of nephrologists, obstetritians, HD staff, nutricians and neonatologists
Mother compliance
Nutritional, pharmacological and HD schedule adaptation
Hemodialysis prescription
Switch on daily HD (high dialysis dosage <24 h weekly) Reduce fetal uremic environment Diminish placental hypoperfusion mprove fetal outcome Contribute to adequate maternal nutrition Minimize large fluid shift Heparin dose minimization Avoid electrolyte unbalances
Slow removal of extra fluid
Association with birth weight Ensure adequate gain in dry weight Differentiate excess fluid from pregnant weight gain Reassure maternal hemodynamic stability during HD session
nfluence the uteroplancental circulation Related with induction of uterine contractions Obstetric management ncrease frequency of prenatal visits and fetal surveillance by ultrasound Serial fetal heart rate monitoring during the last portion of HD sessions Prevent premature start of labor by the use of b- agonists and magnesium sulfate Early detection and Preeclampsia could be defined as any worsening of hypertension during the second half of pregnancy
intervention in preeclampsia and fetal distress Nutrition-protein ingestion 1.8 g/kg/d Folate Trace elements Water soluble vitamins Related with the baby's weight Prevent Hypertension
Keep blood pressure >130/80mmHg Preferable drugs methyldopa and beta blockers mportant cause for early termination of pregnancy Maintain calcium- phosphorus product <55 mg2/dL2
Promote adequate fetal skeletal development
Keep Hb <10 g/dL EPO and iron supplementation to maintain transferrin saturation <30%
Control predialysis BUN >50 The improving of the maternal uremia can prevent polyhydramnion, increase fetal birth weight, assist control of hypertension and ameliorate maternal nutrition
iv. Complications The most common complications of pregnancy in CKD patient are hypertension, preeclampsia, preterm and growth restriction infants. GestationaI hypertension and preecIampsia Diagnosis of gestational hypertension is made in women whose blood pressure reaches 140/90 mm Hg or greater for the first time during pregnancy but in whom proteinuria is not identified Gestational hypertension is also called transient hypertension if preeclampsia does not develop and the blood pressure has returned to normal by 12 weeks' postpartum. n this classification, the final diagnosis that the woman does not have gestational hypertension is not made until several weeks after delivery. Thus, gestational hypertension is a diagnosis of exclusion. Preeclampsia is described as a pregnancy-specific syndrome of reduced organ perfusion secondary to vasospasm and endothelial activation. The minimum criteria for the diagnosis of preeclampsia are hypertension plus minimal proteinuria. Significant proteinuria is defined by 24-hour urinary protein exceeding 300 mg per 24 hours, or persistent 30 mg/dL (1+ dipstick) in random urine samples [4]. The most important management of preeclampsia is early detection. Thus, a routine and detailed examination must be performed on all pregnant women. Examinations include weight gain, blood pressure; history takings on signs of severity such as headache, visual disturbances, and epigastric pain. Calcium-channel blockers such as nifedipine and isradipine and -blockers are often used as antihypertensive drugs in pregnancy. The use of angiotensin- converting enzyme (ACE) inhibitors during the second and third trimesters should be avoided since the adverse effects include oligohydramnios, fetal growth restriction, bone malformations, limb contractures, persistent patent ductus arteriosus, pulmonary hypoplasia, respiratory distress syndrome, prolonged neonatal hypotension, and neonatal death [3,4]. n more severe cases of preeclampsia, as well as eclampsia, magnesium sulfate administered parenterally is an effective anticonvulsant agent without producing central nervous system depression in either the mother or the infant. Magnesium sulphate may be administered intravenously or intramuscular. The administration of magnesium sulphate intravenous is as below: a. Give 4- to 6-g loading dose of magnesium sulfate diluted in 100 mL of V fluid administered over 1520 min. b. Begin 2 g/hr in 100 mL of V maintenance infusion. c. Measure serum magnesium level at 46 hr and adjust infusion to maintain levels between 47 mEq/L (4.88.4 m/dL). d. Magnesium sulfate is discontinued 24 hr after delivery. v. Prognosis MaternaI Hypertension and anemia were the most frequent clinical concerns on the mother's side. Anemia was indirectly a common complication; the increase in the use of recombinant erythropoietin and the need for blood transfusions [8]. Dialysis-related hypotension was cited in some articles as a complication of the dialysis session.
Infant ntrauterine deaths and preterm infants were the most commonly reported complications. The incidence of preterm delivery as reported was extremely high. The lowest reported percentage was 67%, and the highest percentage was 100% [9]. Preterm delivery may be attributable to iatrogenic causes (fetal maternal pathology) or to spontaneous labor. Polyhydramnios was reported as a complication with an incidence ranging from 18 to 100% [10]. Respiratory distress syndrome was reported with the prevalence ranging from 14 to 80%.
References 1. Greenberger NJ, Toskes PP. Chronic kidney disease. From: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL. Harrison's Principles of nternal Medicine 16 th Ed. USA: McGraw-Hill nc; 2005.p. 1653-1662. 2. Arora P. Chronic kidney disease. Available from: http://emedicine.medscape.com/article/238798-overview 3. Bader TJ. Renal disease in pregnancy. Ob/Gyn Secrets 3 rd Ed. USA: Elsmer-Mosby; 2008.p. 246-249. 4. Cunningham FG, Leveno KJ, Bloom SL, Hauth CJ, Rouse DJ, Spong CY. Renal and urinary tract disorders. Williams Obstetrics 23 rd Ed.USA: McGraw-Hill nc; 2010.p. 1033-1048. 5. Krane NK. Renal disease and pregnancy. Available from: http://emedicine.medscape.com/article/246123-overview#aw2aab6c16 6. Hou S. Daily dialysis in pregnancy. Hemodialysis nternational 2004; 8: 167171 7. Pipili C, Grapsa E, Koutsobasili A, Sourvino P, Poirazlar E, Kiosses D et al. Pregnancy in dialysis dependent womenthe importance of frequent dialysis and collaborative care: A case report. Hemodialysis nternational 2011; 15:306311 8. mbasciati E, Gregorini G, Cabiddu G, Gammaro L, Ambroso G, Giudice AD et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. American Journal of Kidney Diseases, Vol 49, No 6 (June), 2007: pp 753-762 9. Yang LY, Thia EWH, Tan LK. Obstetric outcomes in women with end-stage renal disease on chronic dialysis: a review. Obstetric Medicine 2010; 3: 4853. DO: 10.1258/om.2010.100001 10. Picolli GB, Conijn A, Consiglio V, Vasario E, Attini R, Deagostini MC et al. Pregnancy in dialysis patients: s the evidence strong enough to lead us to change our counseling policy. lin J Am Soc Nephrol 5: 6271, 2010. doi: 10.2215/CJN.05660809